Craft
Bioheng

Bioheng

Total Funding

$94.8 M

Bioheng Summary

Company summary

Overview
Bioheng (also known as Nanjing Beiheng Biotech, 北恒生物) is a biopharmaceutical company that focuses on immunotherapy and gene therapy for treating cancer. It also provides a range of contract research services, including target screening and verification, pre-clinical studies, quality management, CRISPR-CAS9 gene editing, etc.
Type
Private
Status
Active
Founded
2017
HQ
Nanjing, CN | view all locations
Website
https://www.bioheng.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Nanjing, Jiangsu HQ

    China

    Pukou District

Footer menu